Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.75 USD | +0.83% | -1.36% | -3.89% |
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
Benjamin Dake
FOU | Founder | 48 | 18-07-26 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 21-01-31 |
George Eldridge
DFI | Director of Finance/CFO | 61 | 21-02-28 |
Marco Verwijs
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Hunter Gillies
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-04-30 |
Ralph Niven
CTO | Chief Tech/Sci/R&D Officer | 64 | 20-06-30 |
Timothy Pigot
PRN | Corporate Officer/Principal | - | 21-05-31 |
Sue Fischer
PRN | Corporate Officer/Principal | - | - |
Donna Dea
LAW | General Counsel | - | 20-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Santel
BRD | Director/Board Member | 62 | 23-01-18 |
Maha Katabi
BRD | Director/Board Member | 50 | 20-07-31 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 21-01-31 |
Dave Grayzel
BRD | Director/Board Member | 56 | 20-07-31 |
Mark Iwicki
BRD | Director/Board Member | 57 | 21-01-31 |
Joshua Resnick
BRD | Director/Board Member | 49 | 18-09-30 |
Allison Dorval
BRD | Director/Board Member | 48 | 21-07-14 |
Habib Dable
CHM | Chairman | 54 | 23-07-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,862,961 | 27,854,484 ( 99.97 %) | 0 | 99.97 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.89% | 625M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- AVTE Stock
- Company Aerovate Therapeutics, Inc.